An antifungal drug, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis (thrush), serious systemic infections such as cryptococcal meningitis, and others. Such drugs are usually obtained by a doctor's prescription, but a few are available OTC (over-the-counter).
Asia Pacific is expected to be the fastest growing regional segment for the antifungal drug market in 2017 within the forecast period due to the rapid spread of fungal infection in this region. Asia Pacific accounted as a leading market of the global antifungal drug market in 2015 in terms of growth.
The global Antifungal Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Antifungal Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antifungal Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Antifungal Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Antifungal Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Segment by Regions
Segment by Type
Segment by Application